Results 181 to 190 of about 8,517,557 (393)

Melting versus Decomposition of GaN: Ab Initio Molecular Dynamics Study and Comparison to Experimental Data

, 2023
Jacek Piechota, Stanisław Krukowski, B. Sadovyi, Petro Sadovyi, S. Porowski, I. Grzegory   +5 more
openalex   +1 more source

Introduction to molecular dynamics [PDF]

, 2019
Sumit Sharma, Pramod Kumar, Rakesh Chandra   +2 more
openaire   +1 more source

Plecstatin inhibits hepatocellular carcinoma tumorigenesis and invasion through cytolinker plectin

Molecular Oncology, EarlyView.
The ruthenium‐based metallodrug plecstatin exerts its anticancer effect in hepatocellular carcinoma (HCC) primarily through selective targeting of plectin. By disrupting plectin‐mediated cytoskeletal organization, plecstatin inhibits anchorage‐dependent growth, cell polarization, and tumor cell dissemination.
Zuzana Outla, Jan Kosla, Magdalena Prechova, Lukas Frick, Patricia Bortel, Yasmin Borutzki, Andrea Bileck, Christopher Gerner, Samuel M. Meier‐Menches, Selma Osmanagic‐Myers, Martin Gregor   +10 more
wiley   +1 more source

Molecular Dynamics Simulation of the Interaction of Two Linear Battacin Analogs with Model Gram-Positive and Gram-Negative Bacterial Cell Membranes

, 2020
Aparajita Chakraborty, Elisey Kobzev, Jonathan Chan, Gayan Heruka De Zoysa, Vijayalekshmi Sarojini, Thomas J. Piggot, Jane R. Allison   +6 more
openalex   +1 more source

Probing spatial locality in ionic liquids with the grand canonical adaptive resolution molecular dynamics technique [PDF]

, 2018
B. Shadrack Jabes, Christian Krekeler, Rupert Klein, Luigi Delle Site   +3 more
openalex   +1 more source

Recurrent cancer‐associated ERBB4 mutations are transforming and confer resistance to targeted therapies

Molecular Oncology, EarlyView.
We show that the majority of the 18 analyzed recurrent cancer‐associated ERBB4 mutations are transforming. The most potent mutations are activating, co‐operate with other ERBB receptors, and are sensitive to pan‐ERBB inhibitors. Activating ERBB4 mutations also promote therapy resistance in EGFR‐mutant lung cancer.
Veera K. Ojala, Sini Ahonen, Sara Peltola, Aura Tuohisto‐Kokko, Olaya Esparta, Peppi Suominen, Anne Jokilammi, Iman Farahani, Deepankar Chakroborty, Nikol Dibus, Steffen Boettcher, Tomi T. Airenne, Mark S. Johnson, Lisa D. Eli, Klaus Elenius, Kari J. Kurppa   +15 more
wiley   +1 more source

Semi-rational design and molecular dynamics simulations study of the thermostability enhancement of cellobiose 2-epimerases

, 2019
Qiuming Chen, Yaqin Xiao, Eugene I. Shakhnovich, Wenli Zhang, Wanmeng Mu   +4 more
openalex   +2 more sources

Molecular dynamics study of liquid sodium film evaporation and condensation by Lennard-Jones potential

, 2022
Zetao Wang, Kailun Guo, Chenglong Wang, Dalin Zhang, Wenxi Tian, Suizheng Qiu, G.H. Su   +6 more
openalex   +1 more source

Role of Low Molecular Weight Polymers on the Dynamics of Silicon Anodes During Casting [PDF]

, 2021
Mary K. Burdette‐Trofimov, Beth L. Armstrong, Ryan P. Murphy, Luke Heroux, Mathieu Doucet, Stephen E. Trask, Alexander M. Rogers, Gabriel M. Veith   +7 more
openalex   +1 more source

Phenotypic and genotypic characterization of single circulating tumor cells in the follow‐up of high‐grade serous ovarian cancer

Molecular Oncology, EarlyView.
Single circulating tumor cells (sCTCs) from high‐grade serous ovarian cancer patients were enriched, imaged, and genomically profiled using WGA and NGS at different time points during treatment. sCTCs revealed enrichment of alterations in Chromosomes 2, 7, and 12 as well as persistent or emerging oncogenic CNAs, supporting sCTC identity.
Carolin Salmon, Rui P. L. Neves, Nikolas H. Stoecklein, Sven‐Thorsten Liffers, Jens Siveke, Jan D. Kuhlmann, Pauline Wimberger, Paul Buderath, Rainer Kimmig, Sabine Kasimir‐Bauer   +9 more
wiley   +1 more source